Page last updated: 2024-12-10

healon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

orthovisc: a sodium hyaluronate derivative used to prevent adnexal adhesions [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3084049
MeSH IDM0357383

Synonyms (44)

Synonym
sinovial
suvenyl
chlamyhyaluronic acid sodium salt
arthrease
hyasol
khionat
unii-yse9ppt4th
euflexxa
supartz
ostenil
sodium hyaluronate hmw
nidelon
hyladerm khionat
monovisc
yse9ppt4th ,
euflexxa injection
cystistat
hyaluronsan ha-lq
nrd101
synacid (veterinary)
hyaluronate sodium [usan:jan]
equron (veterinary)
sl-1010
si-4402
hyalovet
hyladerm
healon
ccris 4127
sl 1010
bio hyaluro 12
hyalein
provisc
hyalgan
hyalurone sodium
hyalart
equron
orthovisc
synacid
6-[3-acetamido-2-[6-[3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
AKOS015896610
gtpl4954
sodium (2s,3s,4r,5r,6r)-3-{[(2s,3r,4r,5s,6r)-4-{[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4,5-dihydroxyox
Q27078001
sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (50.00)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.24 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index82.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (42.86%)5.53%
Reviews3 (21.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (35.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]